Since any dysregulation in the JAK-STAT pathway and their regulators may lead to pathological consequences; therefore, signaling pathways are potential therapeutic approaches which targeting of them may lead to develop new strategies in the treatment of different diseases, particularly T cell mediated diseases. Here, SOAT1 is linked to glycogen storage disease VI.